The study by Lin et al. indicated that WT1 intronic variants rs10767935 and rs5030244 may play a role in altering the effects of vitamin D on responses to IFN-β on in MS patients (the group included 71.6% women) [132]. This evidence concerns the gene WT1 and myeloid sarcoma.